Fatal Rhabdomyolysis in a Patient with Liver Cirrhosis after Switching from Simvastatin to Fluvastatin
Baek S, Jang S, Park S, Ok T, Leem J, Lee H, Park S, Kim T. Fatal Rhabdomyolysis in a Patient with Liver Cirrhosis after Switching from Simvastatin to Fluvastatin. Journal Of Korean Medical Science 2011, 26: 1634-1637. PMID: 22148003, PMCID: PMC3230026, DOI: 10.3346/jkms.2011.26.12.1634.Peer-Reviewed Original ResearchConceptsFatal rhabdomyolysisLiver cirrhosisContinuous renal replacement therapyAcute renal failureRenal replacement therapyCoronary artery diseaseHMG-CoA reductase inhibitorsSerum creatine kinaseAsymptomatic elevationIntravenous furosemideRenal failureUrine alkalizationArtery diseaseHepatic failureReplacement therapyMassive hydrationRhabdomyolysisPatientsCirrhosisReductase inhibitorsCreatine kinaseAdverse effectsSimvastatinFluvastatinCandesartan
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply